Market Overview - The Chinese traditional medicine sector experienced a decline of 0.31% on October 27, with Zhenbaodao leading the drop [1] - The Shanghai Composite Index closed at 3996.94, up 1.18%, while the Shenzhen Component Index closed at 13489.4, up 1.51% [1] Stock Performance - Notable gainers in the traditional medicine sector included: - Weikang Pharmaceutical (300878) with a closing price of 23.90, up 3.46% [1] - ST Xiangxue (300147) at 10.25, up 2.60% [1] - Jiuzi Tang (000989) at 10.02, up 2.14% [1] - Conversely, Zhenbaodao (603567) saw a significant decline of 6.23%, closing at 11.13 [2] - Other notable decliners included: - Taiji Group (600129) down 3.21% [2] - Kunming Pharmaceutical Group (600422) down 2.21% [2] Capital Flow - The traditional medicine sector experienced a net outflow of 344 million yuan from institutional investors, while retail investors saw a net inflow of 181 million yuan [2] - The sector's overall capital flow indicated a mixed sentiment, with speculative funds showing a net inflow of 163 million yuan [2] Individual Stock Capital Flow - Key stocks with significant capital flow included: - Jilin Aodong (000623) with a net inflow of 81.97 million yuan from institutional investors [3] - Yunnan Baiyao (000538) with a net inflow of 62.26 million yuan [3] - Jiuzi Tang (000989) with a net inflow of 26.22 million yuan [3] - Notable outflows were observed in: - Jilin Aodong with a retail net outflow of 72.25 million yuan [3] - Yunnan Baiyao with a retail net outflow of 67.54 million yuan [3]

Core Viewpoint - The company has completed a share buyback program, reducing its total share capital and enhancing shareholder value through strategic financial management [5]. Financial Data - The company reported that it has not undergone an audit for the third-quarter financial statements [3]. - The total number of shares repurchased was 5,472,559, which accounts for 0.98% of the company's total share capital, with a total expenditure of 120 million yuan [5]. - Following the share buyback, the total share capital decreased from 556,890,744 shares to 551,418,185 shares, and the registered capital changed from 556,890,744 yuan to 551,418,185 yuan [5]. Shareholder Information - The company confirmed that there were no changes in the major shareholders or the top ten shareholders due to share lending activities [4]. - The company’s actual controller changed from the Fuling District State-owned Assets Supervision and Administration Commission to China National Pharmaceutical Group Corporation, with the ultimate controller being the State-owned Assets Supervision and Administration Commission of the State Council [6][7]. Other Important Information - The company has committed to resolving competition issues with its major shareholder, China National Pharmaceutical Group, by April 14, 2026, through various strategic measures [6][7].

Core Insights - Taiji Group (600129.SH) reported a significant decline in financial performance for the first three quarters of 2025, with revenue of 8.088 billion yuan, representing a year-on-year decrease of 22.49% [1] - The company's net profit attributable to shareholders was 166 million yuan, down 69.56% year-on-year [1] - The non-recurring net profit was 90.84 million yuan, reflecting a substantial decline of 81.85% compared to the previous year [1] - Basic earnings per share stood at 0.30 yuan [1]

Core Viewpoint - Taiji Group announced the appointment of Ms. Yu Jian as the new Chief Financial Officer during the 32nd meeting of the 10th Board of Directors scheduled for October 23, 2025 [1] Group 1 - The company will hold its 32nd meeting of the 10th Board of Directors on October 23, 2025 [1] - The board approved the proposal to appoint Ms. Yu Jian as the Chief Financial Officer [1]

Core Viewpoint - Taiji Group reported a significant decline in both revenue and net profit for the first three quarters of 2025, primarily due to policy impacts and ongoing inventory digestion of certain products [1] Financial Performance - The company's revenue for the first three quarters reached 8.088 billion, representing a year-on-year decrease of 22.49% [1] - The net profit attributable to shareholders was 166 million, reflecting a year-on-year decline of 69.56% [1] Reasons for Decline - The decline in net profit is attributed to several factors, including the impact of relevant policies and the continued digestion of social inventory for certain products [1] - A decrease in sales volume and average selling prices of major products contributed to the revenue drop [1] - The reduction in production led to an increase in the proportion of fixed costs, such as depreciation and amortization, which negatively affected the gross profit margin [1]

Core Viewpoint - Taiji Group (600129.SH) reported a decline in both revenue and net profit for the third quarter, indicating potential challenges in its financial performance [1] Financial Performance - The company achieved a revenue of 2.43 billion yuan in the third quarter, representing a year-on-year decrease of 7.13% [1] - The net profit attributable to shareholders was 27.108 million yuan, down 46.28% year-on-year [1] - Basic earnings per share were reported at 0.05 yuan [1]

截至发稿，太极集团市值为120亿元。 每经头条（nbdtoutiao）——中国创新药，今年海外授权已卖出800亿美元！对话创东方投资合伙人卢 刚：生物医药二级市场火热，一级市场为何募资遇冷？ （记者 张明双） 每经AI快讯，太极集团（SH 600129，收盘价：21.84元）10月24日晚间发布公告称，刘尊义先生因工作 调整原因申请辞去公司财务总监职务。辞职后，刘尊义先生将不再担任公司任何职务。公司审议通过 《关于聘任公司财务总监的议案》，同意聘任余剑女士为公司财务总监。 2024年1至12月份，太极集团的营业收入构成为：工业占比56.82%，商业占比54.42%，中药材资源占比 8.5%，大健康及国际占比3.72%，其他业务占比1.22%。 ...

证券代码：600129 证券简称：太极集团 公告编号：2025-080 重庆太极实业（集团）股份有限公司 关于拟通过公开竞价方式受让控股子公司 部分股权暨下属子公司减资的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、 误导性陈述或者重大遗漏，并对其内容的真实性、准确性和完整性承 担法律责任。 重要提示 1.重庆市涪陵区城乡资产管理有限公司（以下简称：涪陵城乡公 司）为重庆太极实业（集团）股份有限公司（以下简称：公司）下属 部分控股子公司的参股股东，为进一步理顺下属公司股权管理，规范 法人治理，涪陵城乡公司拟通过公开挂牌转让或减资的方式，整体退 出对公司下属 8 家控股子公司的参股投资。 2.涪陵城乡公司退出公司下属控股子公司参股投资后，将不再持 有公司下属子公司股权，公司合并报表范围不会发生变化。 3.上述事项不涉及关联交易，也不构成《上市公司重大资产重组 管理办法》规定的重大资产重组。依据《公司章程》的有关规定，本 议案无需提交股东会审议。 一、交易概述 涪陵城乡公司为公司下属部分控股子公司的参股股东，为进一步 理顺下属公司股权管理，规范法人治理，涪陵城乡公司拟通过公开挂 牌转让或减资的方式 ...

重庆太极实业（集团）股份有限公司 章 程 二 0 二五年十月 - 1 - 第一条 为维护重庆太极实业（集团）股份有限公司（以 下简称公司）、股东、职工和债权人的合法权益，规范公司的组 织和行为，根据《中华人民共和国公司法》（以下简称《公司法》）、 《中华人民共和国证券法》（以下简称《证券法》）和其他有关 规定，制定本章程。 第二条 公司系依照《公司法》和其他有关规定成立的股 份有限公司。 公司于 1993 年 12 月 28 日在涪陵市工商行政管理局注册登 记，取得营业执照，1997 年经重庆市人民政府重府函（1997） 73 号文批准，公司由定向募集公司变为社会募集公司。并按《公 司法》等有关法律法规的规定进行了规范，依法履行了重新登 记手续。 公司社会统一信用代码：91500102208507353E 第三条 公司于 1997 年 9 月 15 日，经中国证券管理委员 会证监发字（1997）458 号文批准，首次向社会公众发行人民币 普通股 5,000 万股，于 1997 年 11 月 18 日在上海证券交易所上 市。 第四条 公司注册名称： 中文全称：重庆太极实业（集团）股份有限公司 英文全称：CHON ...

| 姓名 | 离任职务 | 离任时间 | 原定任期 | | 是否继续在上 | 具体职务 | 是否存在 未履行完 | | --- | --- | --- | --- | --- | --- | --- | --- | | | | | 到期日 | 离任原因 | 市公司及其控 股子公司任职 | （如适用） | 毕的公开 承诺 | | 刘尊义 | 财务总监 | 2025 年 10 | 第十届董 事会任期 | 工作变动 | 否 | / | 否 | | | | 月 22 日 | 届满之日 | | | | | 证券代码：600129 证券简称：太极集团 公告编号：2025-077 重庆太极实业（集团）股份有限公司 关于财务总监辞职暨聘任财务总监的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、 误导性陈述或者重大遗漏，并对其内容的真实性、准确性和完整性承 担法律责任。 重要内容提示 ●重庆太极实业（集团）股份有限公司（以下简称：公司）董事 会于近日收到公司财务总监刘尊义先生的书面辞职报告，刘尊义先生 因工作调整原因申请辞去公司财务总监职务。辞职后，刘尊义先生将 不再担任公司任何职务。 ●公司于 2025 年 ...